Evidence map›Paper›PMID 38707913›Full record

ArticleEClinicalMedicine2024

Anti-stigma interventions in low-income and middle-income countries: a systematic review.

Tazeen Majeed, Gareth Hopkin, Katie Wang, Smriti Nepal, Nicole Votruba, Petra Gronholm, Dristy Gurung, Maya Semrau, Tanmay Bagade, Nick Farina and 6 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Tazeen MajeedSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Australia.
Gareth HopkinNational Institute for Health and Care Excellence, United Kingdom.
Katie WangDepartment of Social and Behavioral Sciences, Yale School of Public Health, United Kingdom.
Smriti NepalSax Institute, New South Wales, Australia.
Nicole VotrubaCentre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Petra GronholmCare Policy and Evaluation Centre, London School of Economics and Political Science, London, United Kingdom.
Dristy GurungCentre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Maya SemrauCentre of Excellence for Global Health Research, Brighton & Sussex Medical School, Brighton, UK.
Tanmay BagadeSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Australia.
Nick FarinaFaculty of Health, University of Plymouth, Plymouth, UK.
Christine MusyimiAfrica Mental Health Research and Training Foundation.
Luca PinganiDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Erica BreuerSchool of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Australia.
Crick LundCentre for Implementation Science and Centre for Global Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Graham ThornicroftCentre for Implementation Science and Centre for Global Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Sara Evans-LackoCare Policy and Evaluation Centre, London School of Economics and Political Science, London, United Kingdom.

Funding

RESHAPE Diversity SupplementR01MH120649 · NIMH · GEORGE WASHINGTON UNIVERSITY · PI KOHRT, BRANDON ALAN · 2019 to 2023
$3.5M
Mental illness stigma as a risk factor for substance use among adults with depressionK01DA045738 · NIDA · YALE UNIVERSITY · PI WANG, PENG · 2019 to 2023
$886k
NIDA NIH HHS K01 DA045738NIMH NIH HHS R01 MH120649
6 · The paper itself

Abstract

Background: Stigma exacerbates power imbalances and societal disparities, significantly impacting diverse identities and health conditions, particularly for low and middle-income countries (LMICs). Though crucial for dismantling harmful stereotypes, and enhancing healthcare utilisation, existing research on anti-stigma interventions is limited with its condition-focused approach. We aimed to thoroughly evaluate peer-reviewed and non-peer-reviewed literature for a comprehensive review of anti-stigma interventions for diverse identities and all health conditions in LMICs. Methods: This review systematically explored peer-reviewed and non-peer-reviewed literature, in ten electronic databases up to January 30, 2024, covering all anti-stigma interventions across various stigmatised identities and health conditions in LMICs. Quality assessment for this systematic review was conducted as per Cochrane Collaboration's suggested inclusions. The review was registered with PROSPERO (Registration: 2017 CRD42017064283). Findings: Systematic synthesis of the 192 included studies highlights regional imbalances, while providing valuable insights on robustness and reliability of anti-stigma research. Most studies used quasi-experimental design, and most centred on HIV/AIDS or mental health related stigma, with very little work on other issues. Certain high-population LMICs had no/little representation. Interpretation: The interventions targeted diverse segments of populations and consequently yielded a multitude of stigma-related outcomes. However, despite the heterogeneity of studies, most reported positive outcomes underscoring the effectiveness of existing interventions to reduce stigma. Funding: This study is supported by the UK Medical Research Council Indigo Partnership (MR/R023697/1) award.

Indexed as

InterventionLMICsLower-middle income countriesLow-income countriesStigmaSystematic reviewUpper-middle income countries

Identifiers

PMID38707913
PMCPMC11066569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.